[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-353595-105":59,"doc-detail-353595-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","a-streamlined-protocol-for-developing-a-clinicopathological-prediction-model-for-patient-survival-of-post-resection-of-pancreatic-cancer","A Streamlined Protocol for Developing a Clinicopathological Prediction Model for Patient Survival of Post-Resection of Pancreatic Cancer","","Pancreatic ductal adenocarcinoma (PDA) has poor long-term outcomes and surgery is the only curative option, making post-resection survival prediction essential for guiding treatment selection. A streamlined protocol integrates tumor immunological features with clinical variables to build an overall survival prediction model. Multiplex immunohistochemistry on human tumor microarrays is combined with retrospective clinical data from 79 patients, with LASSO feature selection and Cox proportional hazards modeling. Model discrimination and calibration are evaluated via time-dependent AUC, calibration plots, decision curve analysis, and bootstrap validation.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/a-streamlined-protocol-for-developing-a-clinicopathological-prediction-model-for-patient-survival-of-post-resection-of-pancreatic-cancer/353595/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/a-streamlined-protocol-for-developing-a-clinicopathological-prediction-model-for-patient-survival-of-post-resection-of-pancreatic-cancer/353595.png","ImageObject",300,407,{"name":92,"@type":93},"Eliana","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-14","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is predicting survival after pancreatic cancer resection important?","Question",{"text":112,"@type":113},"Survival after resection is limited and many patients face recurrence or poor outcomes. Predicting long-term survival supports patient selection for subsequent therapies.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What data sources were used to develop the prediction model?",{"text":117,"@type":113},"The model combined tumor immunological features from multiplex immunohistochemistry on tissue microarray samples with retrospectively collected clinical data from 79 patients.",{"name":119,"@type":110,"acceptedAnswer":120},"Which variables and modeling methods were used for the final prediction model?",{"text":121,"@type":113},"Variables were selected using LASSO regression with 10-fold cross-validation, and the prediction model was developed with Cox proportional hazards regression using factors such as MHC I intensity, CD4+ T cell ratio, resection margin status, and tumor T stage.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},353595,1790431578,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":36,"preview_page_count":19,"preview_urls":145},4398048949847,"https://ap-avatar.wpscdn.com/avatar/400002536579ef2da7f?_k=1778318612642679267","Cancer Medicine  \n|  RESEARCH ARTICLE  OPEN ACCESS \u003Cbr>A Streamlined Protocol for Developing a Clinicopathological Prediction Model for Patient Survival of Post-Resection of Pancreatic Cancer\u003Cbr>Yi Ma1,2 | Eunice Lee1,3 | Khashayar Asadi4 | Mehrdad Nikfarjam1,3 | Hong He1 \u003Cbr>1Department of Surgery, University of Melbourne, Austin Precinct, Melbourne, Victoria, Australia | 2Department of General Surgery, Monash Health, Melbourne, Victoria, Australia | 3Department of Hepato-Pancreato-Biliary Surgery, Austin Health, Melbourne, Victoria, Australia | 4Department of Anatomical Pathology, Austin Health, Melbourne, Victoria, Australia\u003Cbr>Correspondence: Hong He ([hong.he@unimelb.edu.au](hong.he@unimelb.edu.au))\u003Cbr>Received: 26 October 2025 | Revised: 30 December 2025 | Accepted: 3 January 2026\u003Cbr>Keywords: CD4+ | CD8+ | CK19 | MHC I | overall survival | pancreatic cancer | post-resection |  |\n| --- | --- |\n| ABSTRACT\u003Cbr>Background: Pancreatic ductal adenocarcinoma (PDA) is one of the most malignant solid cancers. As surgery is the only cure, prediction of long-term survival post-resection is critical to guide patient selection for the subsequent treatment. Tumour immune evasion plays a key role in PDA tumorigenesis.\u003Cbr>Materials and Methods: Using a streamlined protocol, we developed a clinicopathological prediction model for the overall survival of patients with PDA after resection by integrating tumour immunological features and clinical data. Multiplex immunohistochemistry was performed using human tumour microarray samples. The results were combined with retrospectively collected clinical data of 79 patients. Variables were selected by least absolute shrinkage and selection operator (LASSO) regression with 10-fold cross-validation to develop the prediction model. The performance of the model was assessed using the concordance index, receiver operating characteristic curve, calibration plot and decision curve analysis. The model was validated by bootstrap resampling. Results: Cancer cell MHC I intensity, CD4+ T cell to tumour cell ratio, resection margin status and tumour T stage were identified for prediction model development using Cox proportional hazard regression. Discrimination of developed model was moderate on the time-dependent area under curve at one (0.698), three (0.765) and five (0.825) years. A small decrease in the overall c-index from 0.67 to 0.652 was shown in the internal validation by bootstrapping.\u003Cbr>Conclusion: Our protocol provided a framework for developing a complex model that will significantly contribute to clinical practice. |  |\n| 1 | Introduction | patients have metastatic disease upon diagnosis, thus unsuitable for surgery [2] . Even with successful surgical resection, |\n| Pancreatic ductal adenocarcinoma (PDA) is one of the most | most patients develop cancer recurrence, and only 25% of pa- |\n| malignant solid cancers, with less than 10% five-year survival | tients can survive more than 5 years [2] . Given the poor prog- |\n| [1] . While surgery remains the only hope of cure, 50%–60% of | nosis, the prediction of post-resection survival in individual |\n| Abbreviations: AIC, Akaike information criterion; AJCC, American joint committee on cancer; AUC, area under curve; CD, cluster of differentiation; CK, Cytokeratin; Cox PH regression, Cox proportional hazard regression; CV, cross validation; DCA, decision curve analysis; Dxy, Somer's delta; IQR, inter-quantile range; LC3B, microtubule-associated protein 1 light chain 3 beta; MHC, major histocompatibility complex; mIHC, multiplex immunohistochemistry; PAK, P21-activated kinase; PCA, principal component analysis; PDA, pancreatic ductal adenocarcinoma; ROC curve, receiver operating characteristic curve; RT, room temperature; TMA, tissue microarray; TME, tumour microenvironment; TRIPOD, transparent reporting of a multivariable prediction model for individual prognosis or diagnosis; VIF, variance inflation factor. |  |\n| This is an open access article unde","cbCailTdC5ut8o9Z","https://ap.wps.com/l/cbCailTdC5ut8o9Z","pdf",5157209,16,"English","# Abstract\n## Background\n## Materials and Methods\n## Results\n## Conclusion\n# Introduction","[{\"question\":\"Why is predicting survival after pancreatic cancer resection important?\",\"answer\":\"Survival after resection is limited and many patients face recurrence or poor outcomes. Predicting long-term survival supports patient selection for subsequent therapies.\"},{\"question\":\"What data sources were used to develop the prediction model?\",\"answer\":\"The model combined tumor immunological features from multiplex immunohistochemistry on tissue microarray samples with retrospectively collected clinical data from 79 patients.\"},{\"question\":\"Which variables and modeling methods were used for the final prediction model?\",\"answer\":\"Variables were selected using LASSO regression with 10-fold cross-validation, and the prediction model was developed with Cox proportional hazards regression using factors such as MHC I intensity, CD4+ T cell ratio, resection margin status, and tumor T stage.\"}]","A Streamlined Protocol for Developing a Clinicopathological Prediction Model for Patient Survival of Post-Resection of Pancreatic Cancer | PDF",1790106228,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a6b28c07805a078941de097cfe095a80.webp",983,1291,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/92330dfdd402968dee3438d1a9d58a97.webp",982,1290,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4b30689b6b70d3f766ce4fccc6c89de9.webp",981,1289,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ed78155203576c0a3ede02871a143014.webp",980,1287]